SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Midnight (NIGHT) is a cryptocurrency launched in 2025and operates on the BNB Smart Chain (BEP20) platform. Midnight has a current supply of 24,000,000,000 with 16,607,399,401 in circulation. The last known price of Midnight is 0.0466466 USD and is up 2.42 over the last 24 hours. It is currently trading on 208 active market(s) with $45,021,965.41 traded over the last 24 hours. More information can be found at https://midnight.network/.

Midnight

Midnights mainnet launch and announcements around institutional use, including Monument Banks planned tokenized deposits, are drawing attention to its privacy-focused blockchain. Traders are split: some see these developments as a foundation for adoption, while others question the rollouts decentralization and note that the token has struggled to sustain gains.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit is drawing attention around the FDA decision on ivonescimab for EGFR-mutated lung cancer, a high-stakes catalyst for the companys lead drug. Traders are divided: supporters point to strong progression-free-survival results and improving survival trends, while skeptics focus on the missed statistical-significance threshold for overall survival and the FDAs stated requirement.

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 1.0099454 USD and is down -2.36 over the last 24 hours. It is currently trading on 1896 active market(s) with $2,532,309,467.05 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

XRPs sharp decline toward and below the psychologically important $1 level amid a broader crypto selloff is dominating discussion, with traders pointing to Bitcoin weakness, leveraged long liquidations and inflation-driven concerns about interest rates. The community is split between bearish calls for further losses and holders treating the dip as a buying opportunity.

Cardano (ADA) is a cryptocurrency launched in 2017. Cardano has a current supply of 44,994,648,344.194204 with 36,816,370,531.313927 in circulation. The last known price of Cardano is 0.16792499 USD and is down -4.07 over the last 24 hours. It is currently trading on 1752 active market(s) with $304,416,326.91 traded over the last 24 hours. More information can be found at https://www.cardano.org.

Cardano

Cardano is drawing attention amid a broader crypto selloff and persistent selling pressure, with traders voicing frustration over its decline and questioning whether support will hold. Some are buying the dip and anticipating a rebound, but bearish views about further losses and crypto weakness are prominent.

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,111,631. The last known price of Bitcoin is 68,229.80907922 USD and is down -4.02 over the last 24 hours. It is currently trading on 12780 active market(s) with $42,739,134,877.94 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

Bitcoins steep selloff and break below key technical support dominate the conversation, with many traders warning of further downside and others arguing oversold conditions could bring a bounce. Debate centers on whether the decline marks a deeper bear trend or a buying opportunity, with some traders also pointing to rising yields and ETF outflows as possible headwinds.

AGNC Investment Corp. engages in the operation of a real estate investment trust. The firm invests in residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by the United States government-sponsored enterprise or by the United States government agency. It also invests in other types of mortgage and mortgage-related securities, such as credit risk transfer securities and non-Agency residential and commercial mortgage-backed securities, where repayment of principal and interest is not guaranteed by the United States government-sponsored enterprise or by the United States Government agency, and other assets related to the housing, mortgage, or real estate markets. The company was founded on January 7, 2008 and is headquartered in Bethesda, MD.

AGNC Investment Corp

AGNCs latest quarterly results showed a sharp decline in tangible book value and a negative economic return, intensifying pressure on shares as rising Treasury yields and mortgage-bond spreads weigh on the mortgage REIT. Traders are debating whether the high monthly dividend is sustainable, while others view the selloff and depressed share price as a buying opportunity.

XMAX, Inc. engages in design, marketing, and manufacture of modern home furniture. The firm offers living room, urban dining, bedroom, and nova qwik products. Its brands include Nova LifeStyle, Diamond Sofa, and Nova Living. The company was founded by Ya Ming Wong and Yuen Ching Ho in 1992 and is headquartered in Commerce, CA.

XMax Inc.

XMaxs pivot from furniture distribution toward AI infrastructure is drawing attention, especially its five-year agreement for dedicated NVIDIA Blackwell GPU capacity and projected AI-services revenue, alongside moves into GaN power semiconductors. Bulls see concrete infrastructure progress, while skeptics question whether the company can commercialize the plans and deliver meaningful revenue.

Alaska Air Group, Inc. is a holding company, which engages in the provision of air transportation services. It operates through the following segments: Alaska Airlines, Hawaiian Airlines, and Regional. The Alaska Airlines segment includes scheduled air transportation on Alaska's Boeing and Airbus jet aircraft for passengers and cargo. The Hawaiian Airlines segment refers to scheduled air transportation on Hawaiian's Boeing and Airbus aircraft for passengers and cargo. The Regional segment consists of Horizon's and other third-party carriers’ scheduled air transportation on E175 aircraft for passengers under CPAs. The company was founded in 1985 and is headquartered in Seattle, WA.

Alaska Air Group Inc.

The FAAs nationwide ground stop prompted Alaska Air to cancel and divert some mainland flights, drawing attention to the short-term operational impact. Traders debated the cause and significance of the disruption, while some viewed the orders lifting as a relief for airline shares.

Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia on January 10, 1989 and is headquartered in Carlsbad, CA.

Ionis Pharmaceuticals Inc

Ioniss sharp selloff followed a cut to TRYNGOLZA sales guidance amid slower-than-expected launch uptake, overshadowing otherwise solid revenue growth and reaffirmed overall guidance. Traders are debating whether the drop is overdone, with some pointing to insider buying and potential stabilization while others remain concerned about commercial execution and further downside.

JasmyCoin (JASMY) is a cryptocurrency launched in 2016and operates on the Ethereum platform. JasmyCoin has a current supply of 50,000,000,000 with 49,444,999,677.16957912 in circulation. The last known price of JasmyCoin is 0.00332184 USD and is down -3.53 over the last 24 hours. It is currently trading on 374 active market(s) with $7,601,758.71 traded over the last 24 hours. More information can be found at https://www.jasmy.co.jp/en_company.html.

JasmyCoin

JASMYs weak price action amid a broader crypto downturn is driving discussion, with holders split between buying dips and criticizing the projects limited visible adoption and communication. Traders also compare its lagging performance with Janctions rallies, while claims of deliberate selling remain speculative.

statis crypto Watchlist

Ethereum

Solana

Dogecoin

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

🚀 $FBLG — FibroBiologics: A Regenerative Medicine Company Worth Watching

Recent preclinical research into spinal disc regeneration highlights the potential of fibroblast-based therapies.

The company is also developing treatments for chronic wounds and other serious conditions.

Could FBLG become a major player in regenerative medicine?

My personal long-term bull-case target is €200 per share, but this is highly speculative and not supported by a validated valuation model.

Clinical results, financing, dilution and regulatory approvals will determine the outcome.

High risk. Significant scientific potential.

#FBLG #Biotech #RegenerativeMedicine

_Christ_is_King_

Peace2026

StockTwits for iOS

FibroBiologics Inc

 — FibroBiologics: A Regenerative Medicine Company Worth Watching

Recent preclinical research into spinal disc regeneration highlights the potential of fibroblast-based therapies.

The company is also developing treatments for chronic wounds and other serious conditions.

Could FBLG become a major player in regenerative medicine?

My personal long-term bull-case target is €200 per share, but this is highly speculative and not supported by a validated valuation model.

Clinical results, financing, dilution and regulatory approvals will determine the outcome.

High risk. Significant scientific potential.

